Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.42 |
| ▸ | ELANE | P08246 | 5/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.41 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.40 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.39 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.39 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.39 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2609246 | 1.00 | HCAR2 (0.54) | HCAR2ALDH1A1TP53HSD17B10ELANE | |
| SCHEMBL16672701 | 0.85 | HCAR2 (0.51) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL16713311 | 0.85 | HCAR2 (0.51) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL16672981 | 0.84 | HCAR2 (0.50) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL26065313 | 0.83 | ELANE (0.47) | HCAR2ALDH1A1ELANE | |
| SCHEMBL4727666 | 0.83 | HCAR2 (0.53) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL27887106 | 0.83 | HCAR2 (0.53) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL5923692 | 0.83 | HCAR2 (0.53) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL682792 | 0.82 | HCAR2 (0.49) | HCAR2ALDH1A1TP53HSD17B10ATM | |
| SCHEMBL16672607 | 0.82 | HCAR2 (0.49) | HCAR2ALDH1A1TP53HSD17B10ATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2072083-B1 | Utilisation of 2.4'-dimethyl-propiophenon as an aroma | SYMRISE AG (DE) | 2012-02-15 | — | — | EP | claimed |
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | SYMRISE GMBH & CO. KG (DE) | 2009-06-25 | — | — | US | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| US-6780835-B2 | DEODORANT FOR TREATING TEXTILES INCORPORATING SPANDEX | QUEST INTERNATIONAL B.V. (NL) | 2004-08-24 | — | — | US | claimed |
| EP-1029032-B1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX CONTAINING FABRICS | UNILEVER PLC (GB) | 2004-03-03 | — | — | EP | claimed |
| US-6660288-B1 | Particularly for mosquitoes; tricyclodecenyl allyl ether perfume (Fleuroxene\"); hydrophobicity such that the common logarithm of the octanol-water partition coefficient, log P, of the perfume ingredient is in the range 1.0 to 6.0 | QUEST INTERNATIONAL B.V. (NL) | 2003-12-09 | — | — | US | claimed |
| EP-1119250-B1 | INSECT REPELLENTS | QUEST INT (NL) | 2002-11-06 | — | — | EP | claimed |
| EP-1119250-A1 | INSECT REPELLENTS | QUEST INTERNATIONAL NEDERLAND BV (NL) | 2001-08-01 | — | — | EP | claimed |
| WO-2000019822-A1 | INSECT REPELLENTS | QUEST INTERNATIONAL B.V. (NL) | 2000-04-13 | — | — | WO | claimed |
| WO-2024073622-A2 | RADIOPHARMACEUTICAL COMPOSITIONS TARGETING EPHRIN TYPE-A RECEPTOR 2 AND USES THEREOF | RAYZEBIO, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | BEIJING TIDE PHARMACEUTICAL CO., LTD. (CN) | 2021-02-25 | — | — | US | disclosed |
| US-10202378-B2 | Therapeutic compounds and uses thereof | GENENTECH, INC. (US) | 2019-02-12 | — | — | US | disclosed |
| US-10006151-B2 | Polyurethane fiber | TORAY OPELONTEX CO., LTD. (JP) | 2018-06-26 | — | — | US | disclosed |
| EP-2947185-B1 | POLYURETHANE FIBER AND ITS USE | TORAY OPELONTEX CO LTD (JP) | 2018-02-28 | — | — | EP | disclosed |
| EP-1023480-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2000-08-02 | — | — | EP | disclosed |
| EP-1021160-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL NEDERLAND BV (NL) | 2000-07-26 | — | — | EP | disclosed |
| WO-2000019822-A1 | INSECT REPELLENTS | QUEST INTERNATIONAL B.V. (NL) | 2000-04-13 | — | — | WO | disclosed |
| WO-1999018926-A1 | PERFUME COMPOSITIONS | QUEST INTERNATIONAL B.V. (NL) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999019452-A1 | LAUNDRY TREATMENT PRODUCTS FOR SPANDEX® CONTAINING FABRICS | UNILEVER PLC (GB) | 1999-04-22 | — | — | WO | disclosed |
| WO-1999019553-A1 | METHOD FOR TEXTILE TREATMENT FOR SPANDEX CONTAINING FABRICS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1999-04-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090162308-A1 | USE OF 2,4'-DIMETHYLPROPIOPHENONE AS A FRAGRANCE SUBSTANCE | CYP1B1, CYP4A22, ROS1 | HCAR2 1953/4885ALDH1A1 17/4885TP53 3237/4885 |
| US-20210054007-A1 | RECEPTOR INHIBITOR, PHARMACEUTICAL COMPOSITION COMPRISING SAME, AND USE THEREOF | TACR1, TACR2, GPBAR1 | HCAR2 79/4885ALDH1A1 1113/4885TP53 4092/4885 |
| US-10202378-B2 | Therapeutic compounds and uses thereof | TAF1, TAF1L, TAF1B | HCAR2 4498/4885ALDH1A1 2132/4885TP53 1865/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.